Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1995 1
1999 2
2000 1
2001 3
2002 1
2003 2
2004 1
2005 3
2006 2
2008 2
2011 1
2012 2
2013 2
2014 5
2015 4
2019 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

32 results
Results by year
Filters applied: . Clear all
Page 1
Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer: A Phase 1 Study.
Emens LA, Cruz C, Eder JP, Braiteh F, Chung C, Tolaney SM, Kuter I, Nanda R, Cassier PA, Delord JP, Gordon MS, ElGabry E, Chang CW, Sarkar I, Grossman W, O'Hear C, Fassò M, Molinero L, Schmid P. Emens LA, et al. Among authors: kuter i. JAMA Oncol. 2019 Jan 1;5(1):74-82. doi: 10.1001/jamaoncol.2018.4224. JAMA Oncol. 2019. PMID: 30242306 Free PMC article. Clinical Trial.
Early detection and prediction of cardiotoxicity in chemotherapy-treated patients.
Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Cohen V, Gosavi S, Carver JR, Wiegers SE, Martin RP, Picard MH, Gerszten RE, Halpern EF, Passeri J, Kuter I, Scherrer-Crosbie M. Sawaya H, et al. Among authors: kuter i. Am J Cardiol. 2011 May 1;107(9):1375-80. doi: 10.1016/j.amjcard.2011.01.006. Epub 2011 Mar 2. Am J Cardiol. 2011. PMID: 21371685 Free PMC article.
Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab.
Ky B, Putt M, Sawaya H, French B, Januzzi JL Jr, Sebag IA, Plana JC, Cohen V, Banchs J, Carver JR, Wiegers SE, Martin RP, Picard MH, Gerszten RE, Halpern EF, Passeri J, Kuter I, Scherrer-Crosbie M. Ky B, et al. Among authors: kuter i. J Am Coll Cardiol. 2014 Mar 4;63(8):809-16. doi: 10.1016/j.jacc.2013.10.061. Epub 2013 Nov 27. J Am Coll Cardiol. 2014. PMID: 24291281 Free PMC article.
Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab.
Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Tan TC, Cohen V, Banchs J, Carver JR, Wiegers SE, Martin RP, Picard MH, Gerszten RE, Halpern EF, Passeri J, Kuter I, Scherrer-Crosbie M. Sawaya H, et al. Among authors: kuter i. Circ Cardiovasc Imaging. 2012 Sep 1;5(5):596-603. doi: 10.1161/CIRCIMAGING.112.973321. Epub 2012 Jun 28. Circ Cardiovasc Imaging. 2012. PMID: 22744937 Free PMC article.
Breast cancer.
Kuter I. Kuter I. Oncologist. 2001;6(4):338-46. doi: 10.1634/theoncologist.6-4-338. Oncologist. 2001. PMID: 11524552 Free article. Review.
A good drug made better: the fulvestrant dose-response story.
Robertson JF, Lindemann J, Garnett S, Anderson E, Nicholson RI, Kuter I, Gee JM. Robertson JF, et al. Among authors: kuter i. Clin Breast Cancer. 2014 Dec;14(6):381-9. doi: 10.1016/j.clbc.2014.06.005. Epub 2014 Jun 24. Clin Breast Cancer. 2014. PMID: 25457991 Review.
Breast cancer highlights.
Kuter I. Kuter I. Oncologist. 1999;4(4):299-308. Oncologist. 1999. PMID: 10476541 Free article. No abstract available.
Breast cancer update.
Kuter I. Kuter I. Oncologist. 2000;5(4):285-92. doi: 10.1634/theoncologist.5-4-285. Oncologist. 2000. PMID: 10964995 Free article.
32 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page